Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.
BMC Cancer
; 17(1): 638, 2017 Sep 08.
Article
in En
| MEDLINE
| ID: mdl-28886696
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endometrial Neoplasms
/
Phosphatidylinositol 3-Kinases
/
PTEN Phosphohydrolase
/
Rad51 Recombinase
/
Poly(ADP-ribose) Polymerase Inhibitors
Limits:
Female
/
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Reino Unido